BetaEntity Annotation Prototype
← Back to institutions

Annotated abstract

Statins: Low risk of side effects should prompt product label changes, researchers say

bmj · 2026-02-05 · canonical JSON source

2 visible annotations · policy: published · automated confidence ≥ 75.00%

Document resource

Product information leaflets for statins should be changed, because they don’t cause the majority of the possible side effects currently listed, say researchers.